TARO - Taro Pharmaceutical EPS beats by $0.41 beats on revenue October, 28 2020 05:18 PM Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical (TARO): Q3 GAAP EPS of $1.18 beats by $0.41.Revenue of $142.84M (-11.2% Y/Y) beats by $17.5M.Press Release For further details see: Taro Pharmaceutical EPS beats by $0.41, beats on revenue